IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells

Immunobiology

Volumn 219, Issue 1, 2014, Pages 17-24

  Curran, Terry Ann ^a   Jalili, Reza Baradar ^a   Farrokhi, Ali ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Allogeneic immune response; Antigen specific immune tolerance; CD4+CD25+ regulatory T cells; Indolamine 2,3 dioxygenase; Transplantation

Indexed keywords

ALLOANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ REGULATORY T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; LYMPHOCYTE COUNT; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN FIBROBLAST; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ALLOGENEIC IMMUNE RESPONSE; ANTIGEN SPECIFIC IMMUNE TOLERANCE; CD4(+)CD25(+) REGULATORY T CELLS; FRIEND LEUKEMIA VIRUS B STRAIN; FVB; GCN2; GENERAL CONTROL NON-DEREPRESSIBLE 2; INDOLAMINE 2,3-DIOXYGENASE; TRANSPLANTATION; TREG;

ANIMALS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CTLA-4 ANTIGEN; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN;

EID: 84888027907     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.06.008     Document Type: Article

References (24)

1. Chung D.J., Rossi M., Romano E., Ghith J., Yuan J., et al. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 2009, 114:555-563.
2. + T regulatory cells. Blood 2007, 109:2871-2877.
3. Dai W., Gupta S.L. Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha. J. Biol. Chem. 1990, 265:19871-19877.
4. Daubener W., Schmidt S.K., Heseler K., Spekker K.C.R.M. Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells. Thromb. Haemost. 2009, 102:1110-1116.
5. Dijke I.E., Weimar W., Baan C.C. Regulatory T cells after organ transplantation: where does their action take place?. Hum. Immunol. 2008, 3:389-398.
6. - regulatory T cells suppress allergic inflammation. J. Immunol. 2011, 187:6499-6507.
7. + T cells. Mol. Cell. Biochem. 2008, 309:1-7.
8. Forouzandeh F., Jalili R.B., Germain M., Duronio V., Ghahary A. Skin cells, but not T cells, are resistant to indoleamine 2,3-dioxygenase (IDO) expressed by allogeneic fibroblasts. Wound Repair Regen. 2008, 16:379-387.
9. Forouzandeh F., Jalili R.B., Hartwell R.V., Allan S.E., Boyce S., et al. Local expression of indoleamine 2,3-dioxygenase suppresses T-cell-mediated rejection of an engineered bilayer skin substitute. Wound Repair Regen. 2010, 18:614-623.
10. Jalili R.B., Forouzandeh F., Rezakhanlou A.M., Hartwell R., Medina A., et al. Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft. Diabetes 2010, 59:2219-2227.
11. Jürgens B., Hainz U., Fuchs D., Felzmann T., Heitger A. Interferon-γ-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood 2009, 114:3235-3243.
12. Katz J.B., Muller A.J., Prendergast G.C. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol. Rev. 2008, 222:206-221.
13. King N.J.C., Thomas S.R. Molecules in focus: indoleamine 2,3-dioxygenase. Int. J. Biochem. Cell Biol. 2007, 39:2167-2172.
14. McCoy K.D., Le Gros G. The role of CTLA-4 in the regulation of T cell immune responses. Immunol. Cell Biol. 1999, 77:1-10.
15. Mills K.H.G. Regulatory T cells: friend or foe in immunity to infection?. Nat. Rev. Immunol. 2004, 4:841-855.
16. Munn D.H., Sharma M.D., Baban B., Harding H.P., Zhang Y., et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005, 22:633-642.
17. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Simon J.C., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998, 281:1191-1193.
18. Onodera T., Jang M.H., Guo Z., Yamasaki M., Hirata T., et al. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions. J. Immunol. 2009, 183:5608-5614.
19. Pfefferkorn E.R., Rebhun S.M.E. Characterisation of an indolamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J. Interferon Res. 1986, 6:267-279.
20. Saada J.I., Pinchuk I.V., Barrera C.A., Adegboyega P.A., Suarez G., et al. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. J. Immunol. 2006, 177:5968-5979.
21. Sprent J. Antigen-presenting cells. Professionals and amateurs. Curr. Biol. 1995, 5:1095-1097.
22. 2 incorporation by a heme-containing dioxygenase. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2611-2616.
23. + regulatory T cells by induction of IDO in endothelial cells. Am. J. Transplant. 2007, 7:2472-2482.
24. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994, 1:405-413.